Territories Medicare Prescription Drug Assistance Equality Act of 2023
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Territories Medicare Prescription Drug Assistance Equality Act of 2023 is a bill introduced in the 118th Congress aimed at addressing Medicare prescription drug assistance for U.S. territories. The bill was referred to the House Subcommittee on Health but did not advance further and is currently classified as failed or expired. Specific provisions, detailed text, and official summary are not available, limiting the ability to provide a detailed description of the bill's content or mechanisms.
This bill sought to modify Medicare prescription drug assistance policies for U.S. territories but did not progress beyond subcommittee referral and is now expired.
- The bill focuses on Medicare prescription drug assistance equality for U.S. territories.
- It was introduced in the House during the 118th Congress and referred to the Subcommittee on Health.
- No full text or official summary is publicly available, and the bill status is failed or expired.
['Residents of U.S. territories who receive Medicare prescription drug assistance', 'Healthcare providers and organizations serving Medicare beneficiaries in U.S. territories', 'Potentially the Centers for Medicare & Medicaid Services (CMS) as the administering agency']
['Lack of publicly available full bill text and summary limits transparency and understanding of implementation requirements', 'Unclear funding mechanisms or authority changes could affect federal budget allocations or territorial healthcare programs', 'Oversight and enforcement provisions are unknown, which may impact accountability']
The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Health on December 17, 2024. It did not advance beyond this stage and is now classified as failed or expired. The bill addresses health policy related to Medicare prescription drug assistance in U.S. territories, an area of ongoing legislative interest due to disparities in federal healthcare benefits between states and territories.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential improvement in healthcare access and prescription drug affordability for Medicare beneficiaries in U.S. territories if enacted', 'Possible administrative adjustments within CMS to accommodate changes in prescription drug assistance policies for territories', "Budgetary impacts on federal healthcare funding allocations depending on the bill's provisions"]
The absence of a full bill text and official summary significantly limits transparency and public understanding of the bill's scope and impact. Oversight bodies and stakeholders would require access to complete legislative language to assess compliance, funding, and enforcement implications. The bill's failure to advance past subcommittee stage further reduces opportunities for public scrutiny and legislative refinement.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.